Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Valiant

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|May 1, 2018
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent SerumWilliam G Valiant, Joseph J Mattapallil
Biologicals : Journal of the International Association of Biological Standardization|November 8, 2022
A history of adventitious agent contamination and the current methods to detect and remove them from pharmaceutical productsWilliam G Valiant, Kang Cai, Peter M Vallone
Biologicals : Journal of the International Association of Biological Standardization|December 29, 2023
Efficient extraction of adventitious virus nucleic acid using commercially available methodsWilliam G Valiant, Jon Borman, Kang Cai, et al.
Open Forum Infectious Diseases|July 19, 2018
Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus InfectionWilliam G Valiant, Tahaniyat Lalani, Heather C Yun, et al.
Emerging Microbes & Infections|July 15, 2018
Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infectionWilliam G Valiant, Yan-Jang S Huang, Dana L Vanlandingham, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cellsKelsi M Sandoz, William G Valiant, Steven G Eriksen, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 13, 2023
Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testingMegan H Cleveland, Erica L Romsos, Carolyn R Steffen, et al.
Scientific Reports|May 29, 2019
Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory CytokinesWilliam G Valiant, Mary J Mattapallil, Stephen Higgs, et al.
The Journal of Comparative Neurology|January 26, 2019
The effect of Zika virus infection in the ferretElizabeth B Hutchinson, Mitali Chatterjee, Laura Reyes, et al.
NPJ Vaccines|March 5, 2025
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infectionAsisa Volz, Sabrina Clever, Alina Tscherne, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|May 1, 2018
A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent SerumWilliam G Valiant, Joseph J Mattapallil
Biologicals : Journal of the International Association of Biological Standardization|November 8, 2022
A history of adventitious agent contamination and the current methods to detect and remove them from pharmaceutical productsWilliam G Valiant, Kang Cai, Peter M Vallone
Biologicals : Journal of the International Association of Biological Standardization|December 29, 2023
Efficient extraction of adventitious virus nucleic acid using commercially available methodsWilliam G Valiant, Jon Borman, Kang Cai, et al.
Open Forum Infectious Diseases|July 19, 2018
Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus InfectionWilliam G Valiant, Tahaniyat Lalani, Heather C Yun, et al.
Emerging Microbes & Infections|July 15, 2018
Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infectionWilliam G Valiant, Yan-Jang S Huang, Dana L Vanlandingham, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2014
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cellsKelsi M Sandoz, William G Valiant, Steven G Eriksen, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 13, 2023
Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testingMegan H Cleveland, Erica L Romsos, Carolyn R Steffen, et al.
Scientific Reports|May 29, 2019
Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory CytokinesWilliam G Valiant, Mary J Mattapallil, Stephen Higgs, et al.
The Journal of Comparative Neurology|January 26, 2019
The effect of Zika virus infection in the ferretElizabeth B Hutchinson, Mitali Chatterjee, Laura Reyes, et al.
NPJ Vaccines|March 5, 2025
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infectionAsisa Volz, Sabrina Clever, Alina Tscherne, et al.
Pageof 2